ISA101 and nivolumab for HPV-16+ cancer: updated clinical efficacy and immune correlates of response

• Jing Wang,
• Lei Feng,
• Qi Wang,
• Erminia Massarelli,
• Renata Ferrarotto,
• Michael A Curran,
• Jack Lee,
• Ignacio Wistuba,
• Cornelis J M Melief,
• Bonnie S Glisson,
• Kimal Rajapakshe,
• Cristian Coarfa,
• William William,
• Luana Guimaraes de Sousa,
• Jaime Rodriguez Canales,
• Renee L Chin,
• Tomas Z Barrese,
• Faye M Johnson

Affiliations

Jing Wang

College of Nursing, Florida State University, Tallahassee, Florida, USA

Lei Feng

19 Radiology, Kaiser Permanente LAMC, Los Angeles, California, USA

Qi Wang

Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada

Erminia Massarelli

Aff23 grid.240145.60000000122914776University of Texas MD Anderson Cancer Center Houston TX USA

Renata Ferrarotto

Department of Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Michael A Curran

1 Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Jack Lee

Division of Biomedical Engineering and Imaging Sciences, King`s College London, London, UK

Ignacio Wistuba

Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Cornelis J M Melief

3 ISA Pharmaceuticals, Leiden, The Netherlands

Bonnie S Glisson

3 Department of Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Kimal Rajapakshe

4 Ahmed Center for Pancreatic Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Cristian Coarfa

6 Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, USA

William William

The University of Texas MD Anderson Cancer Center, Houston, TX, United States

Luana Guimaraes de Sousa

The University of Texas MD Anderson Cancer Center Department of Thoracic Head and Neck Medical Oncology, Houston, Texas, USA

Jaime Rodriguez Canales

Translational Medicine, AstraZeneca, Gaithersburg, Maryland, USA

Renee L Chin

Department of Immunology and Graduate School of Biomedical Sciences, The University of Texas Health Science Center at Houston, Houston, Texas, USA

Tomas Z Barrese

Grupo Fleury, Sao Paulo, Brazil

Faye M Johnson

The University of Texas MD Anderson Cancer Center Department of Thoracic Head and Neck Medical Oncology, Houston, Texas, USA